EpiVacCorona study among adolescents may start in September

TASS reports.

“We will be ready to move on to clinical trials in adolescents immediately after registration of the vaccine on an ongoing basis, after the completion of post-registration clinical trials.

We expect to complete them in September, ”Maksyutov said.

The State Research Center "Vector" previously noted that the Russian vaccine against the coronavirus "EpiVacCorona" is effective against new variants of COVID-19.

Over the past day, 23,564 cases of COVID-19 were detected in Russia.

The total number of cases during the epidemic was 6,242,066.